2011 · 12 citations · 15 references
Life SciencesBiotechnologyMicrobiologyEnzymologyMedical BiotechnologyMolecular BiotechnologyAntibacterial PharmacologyBacterial PathogenesisProtein Expression EngineeringProtein SynthesisTherapeutic Protein EngineeringAmino AcidsBacterial Protein ProductionBacterial Protein SynthesisEscherichia ColiEscherichia Coli Expression SystemsHost Gene ExpressionTherapeutic UsesThrombolytic Enzymes
Staphylokinase, a 163 amino aci d bacterial protein from Staphylococcus aureus is reported to have a therapeutic function and used as a potential alternative for the available clot dissolving drugs and some countries proved to be a potent alternative over the available clot dissolving drugs. In the present study, sak gene is isolated from a lysogenically converted S.aureus and expressed in non-pathogenic E.coli expression host. The sak gene is cloned into pET-28a vector and expressed in an IPTG and salt induced E. coli strain (GJ1158). The mature recombinant sak protein expressed in E.coli is also further extracted and analyzed by various methods to demonstrate thrombolytic activity.
15
Basic and clinical aspects of fibrinolysis and thrombolysis
D Collen, HR Lijnen · Blood · 1991 · 659 citations · Full text
Medicine, Cardiology, Hemostasis +9
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
Sweta Prasad, Rajpal S. Kashyap, Jayant Y Deopujari et al. · Thrombosis Journal · 2006 · 404 citations · Full text